RecruitingPHASE1, PHASE2NCT06315738

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis

Studying Necrotizing enterocolitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Noveome Biotherapeutics, formerly Stemnion
Intervention
ST266(biological)
Enrollment
36 target
Eligibility
All sexes
Timeline
20242029

Study locations (7)

Collaborators

Parexel

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06315738 on ClinicalTrials.gov

Other trials for Necrotizing enterocolitis

Additional recruiting or active studies for the same condition.

See all trials for Necrotizing enterocolitis

← Back to all trials